EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Molecular tumor board: H3K27M diffuse midline glioma diagnosed during pregnancy by cerebrospinal fluid next-generation sequencing

Jason B Sherman iD, Thaddeus D Harbaugh iD, Alexander Sisto iD, Zohaib Sherwani iD, Imraan Jan iD, Jacqueline Norrell iD, Jonathan H Sherman, Vindhya Udhane iD, Kala F Schilter iD, Qian Nie, Honey V Reddi iD, Morana Vojnic iD

The Oncologist · 2026

DOI: 10.1093/oncolo/oyag282 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Oncologist, 2026. Verfasst von Jason B Sherman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Rutgers New Jersey Medical School, 15 South Orange Avenue, Newark, NJ, 07103, United States. Hauptthemen laut MEDLINE: Glioma, High-Throughput Nucleotide Sequencing, Histones, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diffuse midline glioma (DMG) with the H3K27M mutation is an aggressive WHO grade 4 central nervous system tumor characterized by diffuse infiltration of midline structures and a poor prognosis. Molecular characterization is essential for diagnosis and treatment planning; however, obtaining tissue can be infeasible, particularly in anatomically inaccessible locations or medically complex situations, like pregnancy. Patient presentation A 34-year-old G2P1 woman at 19 weeks’ gestation presented with progressive right-sided numbness and weakness. Magnetic resonance imaging demonstrated an infiltrative lesion in the left midbrain extending to the pons and thalamus with intralesional hemorrhage. Differential considerations included diffuse midline glioma and inflammatory demyelinating disease. Molecular findings Because of the lesion location and concerns regarding stereotactic biopsy during pregnancy, cerebrospinal fluid (CSF) next-generation sequencing was pursued. CSF profiling identified an H3K27M mutation, establishing the diagnosis of DMG. Management and outcome Following multidisciplinary discussion involving neuro-oncology, neurology, neurosurgery, radiation oncology, and maternal-fetal medicine, the patient underwent fractionated radiotherapy beginning at 22 weeks’ gestation using pregnancy-shielding techniques. Postpartum dordaviprone (ONC201) therapy was initiated and well tolerated. Follow-up imaging demonstrated radiographic improvement and neurological stabilization, with ongoing response at 12 months post-diagnosis.

Conclusions

The case highlights the utility of CSF liquid biopsy in establishing a molecular diagnosis of diffuse midline glioma when tissue biopsy is contraindicated or deferred. The case also demonstrates how molecular profiling can guide precision oncology in medically complex situations like pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaHigh-Throughput Nucleotide SequencingHistonesBrain NeoplasmsPregnancy Complications, NeoplasticHumansFemalePregnancyAdultMutation

Stichwörter der Autor:innen

Dordaviprone (ONC201)H3K27M mutationcerebrospinal fluid liquid biopsydiffuse midline glioma

Substanzen

Histones

Autor:innen und Institutionen

  • Department of Neurosurgery, Rutgers New Jersey Medical School, 15 South Orange Avenue, Newark, NJ, 07103, United States.
  • Department of Oncology, Rutgers Robert Wood Johnson Medical School, 125 Paterson Street, New Brunswick, NJ, 08901, United States.
  • Rutgers Cancer Institute, 195 Little Albany Street, New Brunswick, NJ 08901, United States.
  • Robert Wood Johnson Barnabas Health, 1 Robert Wood Johnson Place, New Brunswick, NJ 08901, United States.
  • Department of Neurosurgery, Rutgers Robert Wood Johnson Medical School, 125 Paterson Street, New Brunswick, NJ 08901, United States.
  • Belay Diagnostics, Suite 530, 1375 W. Fulton St, Chicago, IL 60607, United States.

ORCID-Profile: Jason B Sherman, Thaddeus D Harbaugh, Alexander Sisto, Zohaib Sherwani, Imraan Jan, Jacqueline Norrell, Vindhya Udhane, Kala F Schilter, Honey V Reddi, Morana Vojnic

Zitieren

APA

Sherman, J. B., Harbaugh, T. D., Sisto, A., Sherwani, Z., Jan, I., Norrell, J., Sherman, J. H., Udhane, V., Schilter, K. F., Nie, Q., Reddi, H. V., & Vojnic, M. (2026). Molecular tumor board: H3K27M diffuse midline glioma diagnosed during pregnancy by cerebrospinal fluid next-generation sequencing. The Oncologist. https://doi.org/10.1093/oncolo/oyag282

Vancouver

Sherman JB, Harbaugh TD, Sisto A, Sherwani Z, Jan I, Norrell J, et al. Molecular tumor board: H3K27M diffuse midline glioma diagnosed during pregnancy by cerebrospinal fluid next-generation sequencing. The Oncologist. 2026. doi:10.1093/oncolo/oyag282

BibTeX
@article{Sherman2026,
  author = {Sherman, Jason B and Harbaugh, Thaddeus D and Sisto, Alexander and Sherwani, Zohaib and Jan, Imraan and Norrell, Jacqueline and Sherman, Jonathan H and Udhane, Vindhya and Schilter, Kala F and Nie, Qian and Reddi, Honey V and Vojnic, Morana},
  title = {Molecular tumor board: H3K27M diffuse midline glioma diagnosed during pregnancy by cerebrospinal fluid next-generation sequencing},
  journal = {The Oncologist},
  year = {2026},
  doi = {10.1093/oncolo/oyag282}
}
Kostenlos starten →